Glioma cells promote the expression of vascular cell adhesion molecule-1 on bone marrow-derived mesenchymal stem cells: a possible mechanism for their tropism toward gliomas.

Journal of Molecular Neuroscience : MN
Yi HuYun-Hui Liu

Abstract

The tropism of bone marrow-derived mesenchymal stem cells (BMSCs) toward gliomas has been shown by in vitro and in vivo assays. This study was carried out to evaluate the role of vascular cell adhesion molecule-1 (VCAM-1) in the migration of BMSCs towards glioma and the effect of glioma cells on the VCAM-1 expression of BMSCs. BMSCs were isolated according to their adherence to plastic. The tropism of BMSCs toward C6 and U87 glioma and the role of VCAM-1 in this migration were analyzed by in vitro migration assay, separately. Reverse transcription-polymerase chain reaction, immunofluorescence, and Western blot were employed to assess VCAM-1 expression of BMSCs when they were incubated by the conditioned mediums (CM) of C6 or U87 glioma cells. Data revealed that C6 and U87 glioma cells promote the migration of BMSCs, which could be blocked by a VCAM-1-neutralizing antibody. Moreover, VCAM-1 expression of BMSCs was elevated by the incubation of their CM. The results also demonstrated that LY294002, an inhibitor of phosphoinositide-3-kinase (PI3K), significantly inhibited the glioma-induced upregulation of VCAM-1 on BMSCs. These findings suggested that glioma-induced change in VCAM-1 expression of BMSCs may play an important role ...Continue Reading

References

Nov 9, 2000·Proceedings of the National Academy of Sciences of the United States of America·K S AboodyE Y Snyder
Apr 2, 2003·Nature Reviews. Immunology·Klaus Okkenhaug, Bart Vanhaesebroeck
May 26, 2004·Neuroscience Letters·Mel TohillGiorgio Terenghi
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Apr 19, 2005·Cancer Research·Akira NakamizoFrederick F Lang
Oct 26, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Vincent F M SegersGilles W De Keulenaer
Jul 15, 2006·Toxicological Sciences : an Official Journal of the Society of Toxicology·Sarah SnykersVera Rogiers
Jun 16, 2007·Journal of Neuro-oncology·Tobias BirnbaumAndreas Straube
May 9, 2008·Journal of Molecular and Cellular Cardiology·Caroline SteingenWilhelm Bloch
May 23, 2008·Neurosurgery·Nader Sanai, Mitchel S Berger
Mar 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Laura S SasportasKhalid Shah
Mar 11, 2009·The Journal of Gene Medicine·Ryosuke UchiboriKeiya Ozawa
Jun 23, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Young-Min HyunMinsoo Kim
Jun 25, 2009·Cancer Research·Cara J LauJosephine Nalbantoglu
Jul 7, 2009·Neuromolecular Medicine·Gokhan Yilmaz, D Neil Granger
Feb 22, 2011·Immunology Letters·Stephen G WardStephanie Harris
Oct 28, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ji Young YooBalveen Kaur

❮ Previous
Next ❯

Citations

Feb 8, 2014·Journal of Hematology & Oncology·Zhao SunRobert Chunhua Zhao
Oct 27, 2017·Oncotarget·Billy Samuel HillAntonella Zannetti
Jul 22, 2018·Neural Regeneration Research·Chang-Geng SongHua Han
Dec 11, 2014·The Journal of Biological Chemistry·Jing-Xian YangQing-Ping Wen

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.